EXELON 3 mg
Generic Name: rivastigmine
Pill imprint EXELON 3 mg has been identified as Exelon 3 mg.
Exelon is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy.
Exelon 3 mg is not subject to the Controlled Substances Act.
See also related documents.
Exelon Images
- Generic Name:
- rivastigmine
- Imprint:
-
EXELON 3 mg
- Strength:
- 3 mg
- Color:
- Orange
- Size:
- 1.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- gelatin
hypromellose
magnesium stearate
microcrystalline cellulose
ferric oxide red
silicon dioxide
titanium dioxide
ferric oxide yellow
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0324
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5839 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More Exelon resources
- Exelon
- Exelon (Wolters Kluwer)
- Exelon Patch (Wolters Kluwer)
- Exelon Solution (Wolters Kluwer)
- Exelon (Cerner Multum)
- Exelon (Micromedex) - Includes Dosage Information
- Exelon Transdermal (Micromedex) - Includes Dosage Information
- Exelon (AHFS DI)
- Exelon (FDA)
- Exelon Patch (FDA)


